NTTVC

Congratulations to Shoreline.io (Acquired by NVIDIA) on its acquisition by NVIDIA! NTTVC partnered with Shoreline at inception through their journey from idea to delivering real-time automation for GPU and AI clouds. Anurag Gupta, Kazi Zaman, and Charles C. will accelerate their vision and make an impact for accelerated AI computing with NVIDIA. cc: Canvas Ventures, Dawn Capital, and Insight Partners

Congratulations to Eko Health on their Series D funding!🎉 We are thrilled to co-lead the round alongside our partners ARTIS Ventures, DigiTx Partners, Highland Capital Partners, and Questa Capital Management to continue supporting Eko on their mission to help patients around the world through AI-powered cardiac and pulmonary disease detection. Read more in TechCrunch from Marina Temkin, CFA: https://lnkd.in/d_bCpRhG cc: Connor Landgraf, Jason Bellet, Subbu Venkatraman

NTTVC portfolio company nference was recently named to Newsweek's list of top 50 best healthcare data analytics companies in the US! Becker's Healthcare featured the list of the data analytics-focused digital health companies. Check it out: https://lnkd.in/eg4Y_Daa cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, Mike Koenig, John Halamka, M.D., M.S., Zachi Attia, Andy Danielsen, Mayo Clinic, Mayo Clinic Ventures #digitalhealth #dataanalytics #healthcare #healthcaredata #newsweek #top50

Congrats to Seemplicity on being named Cyber Defense Magazine's Editor’s Choice for Vulnerability Assessment, Remediation and Management at the Global Infosec Awards 2024 competition! cc: Yoran Sirkis, Ravid Circus, Rotem Cohen Gadol #GIAWinners #GlobalExcellence #RSAC

Excited to see how Pramana is helping transform the digital pathology market and has digitized over 6.5 million glass slides and validated 15 billion images with near-perfect accuracy using Pramana’s in-line quality assurance algorithms. Congratulations and more to come! “Our strides in advancing digital pathology, in collaboration with Image Management System partners, have led to the creation of the largest DICOM dataset for digital pathology, paving the way for a future where proprietary image formats are no longer necessary and marking a new era in digital pathology.” – Prasanth Perugupalli, Pramana Chief Product Officer. Read more about how they are revolutionizing the landscape of pathology labs: https://lnkd.in/eH4FF5zx cc: Murali Aravamudan, Prasanth Perugupalli, Mike Koenig, Duke University School of Medicine, Mayo Clinic #digitalpathology #pathology #AI #GenAI 

Congratulations, Anumana, on receiving the 2024 MedTech Breakthrough Award for Best New Technology Solution in the Cardiology category!👏 We’re excited to see your suite of ECG-AI™ algorithms honored by Tech Breakthrough and the cardiology community. cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, John Halamka, M.D., M.S., Andy Danielsen, Mayo Clinic Ventures, Paul Friedman, Maulik Nanavaty, Charanjit (Chet) Rihal #medtech #healthtech #medtechbreakthrough #cardiology #healthcareinnovation #AI #GenAI

We're thrilled to support Neysa Networks in their $20m seed funding. Welcome to the NTTVC portfolio! India's first GPU AI cloud and platform-as-a-service company will use the funding to accelerate #generativeAI adoption for enterprises. Neysa co-founder and CEO Sharad Sanghi helped fuel the growth of the internet and cloud in India. We are looking forward to working with you again, Sharad Sanghi and Anindya Das. Read more in Entrepreneur India: https://lnkd.in/eBVPcQ55 cc: Jishnu B., Avnish Bajaj, BV Jagadeesh, Abhijit Dubey, Charlie Li, NTT DATA, Inc., NTT Global Data Centers and Cloud Infrastructure, India, Vab Goel, Fay Hazaveh Costa #AI #generativeAI #enterpriseAI #genAI #funding #seedfunding

A big congratulations to Eko Health on receiving FDA clearance for its Low EF detection AI, developed in collaboration with Mayo Clinic. Low ejection fraction is a primary source of heart failure and can now be detected during routine physical examinations in just 15 seconds using an Eko stethoscope. “The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with—the stethoscope—can help us prevent hospitalizations and adverse events. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.” - Mayo Clinic Cardiovascular Medicine Department Chair, Paul Friedman, M.D.   Read more in Fierce Biotech: https://lnkd.in/gV4Khbcr   cc: Connor Landgraf, Jason Bellet, Subbu Venkatraman, Mayo Clinic Ventures, John Halamka, M.D., M.S.  #fdacleared #digitalhealth #stethoscope #ai #healthtech

Thrilled to see two NTTVC portfolio companies – Anumana and Eko Health – featured on The TODAY Show! Dr. Paul Friedman, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, shares how doctors are now able to use artificial intelligence to screen for deadly heart conditions, ultimately saving lives.    Tune in to watch the segment: https://lnkd.in/eYw3PqUD    #ai #artificialintelligence #ecg #heartdisease cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, John Halamka, M.D., M.S., Zachi Attia, Andy Danielsen, Mayo Clinic Ventures, Connor Landgraf, Jason Bellet, Subbu Venkatraman

Congratulations to the team at nference on their recently announced multi-year licensing agreement with the Bill & Melinda Gates Foundation.    nference's nSights platform will enable researchers at the Gates Foundation to access a repository of clinical data to investigate the most pressing issues affecting world health today, ultimately advancing health equity.    Learn more: https://lnkd.in/e92HsUr3   #healthequity #aiforgood #billgates #healthtech  cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, John Halamka, M.D., M.S., Zachi Attia, Andy Danielsen, Mayo Clinic, Mayo Clinic Ventures